Denying access to psilocybin for palliative care patients seems arbitrary and cruel, advocates say.
Spencer Hawkswell, CEO of Victoria-based non-profit TheraPsil, says that a number of patients who applied for access under Section 56 of the Controlled Drugs and Substances Act have recently been denied.
Share this post
